{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:02:09Z","timestamp":1780524129661,"version":"3.54.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0234700","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T17:45:45Z","timestamp":1592329545000},"page":"e0234700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection"],"prefix":"10.1371","volume":"15","author":[{"given":"Ock-Hwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Wook","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5783-6795","authenticated-orcid":true,"given":"Shinhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ha","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heungsup","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-816X","authenticated-orcid":true,"given":"Tae Sun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"pone.0234700.ref001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4046\/trd.2015.78.2.56","article-title":"Diagnosis and treatment of latent tuberculosis infection","volume":"78","author":"SH Lee","year":"2015","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"pone.0234700.ref002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4046\/trd.2017.0052","article-title":"Treatment of latent tuberculosis infection and its clinical efficacy","volume":"81","author":"HW Kim","year":"2018","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"pone.0234700.ref003","volume-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018"},{"key":"pone.0234700.ref004","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. Latent tuberculosis infection in the United States","volume":"364","author":"CR Horsburgh","year":"2011","journal-title":"N Engl J Med"},{"key":"pone.0234700.ref005","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"H Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"pone.0234700.ref006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"pone.0234700.ref007","volume-title":"Tuberculosis diagnostics technology and market landscape 2014","author":"UNITAID, World Health Organization","year":"2014"},{"key":"pone.0234700.ref008","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB Gold Plus for detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"L Yi","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0234700.ref009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"LD Jasenosky","year":"2015","journal-title":"Immunol Rev"},{"key":"pone.0234700.ref010","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"L Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"pone.0234700.ref011","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.13-1232","article-title":"Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study","volume":"145","author":"JL Johnson","year":"2014","journal-title":"Chest"},{"key":"pone.0234700.ref012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","article-title":"Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"IM Adetifa","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0234700.ref013","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"V Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"pone.0234700.ref014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection","volume":"75","author":"M Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pone.0234700.ref015","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3201\/eid2111.141894","article-title":"Achievements in and challenges of tuberculosis control in South Korea","volume":"21","author":"JH Kim","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"pone.0234700.ref016","volume-title":"QuantiFERON-TB Gold Plus (QFT-Plus) ELISA package insert","author":"Qiagen","year":"2015"},{"key":"pone.0234700.ref017","volume-title":"QuantiFERON-TB Gold In-Tube package insert","author":"Cellestis Limited","year":"2006"},{"key":"pone.0234700.ref018","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"ES Theel","year":"2018","journal-title":"J Clin Microbiol"},{"key":"pone.0234700.ref019","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"ML McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"pone.0234700.ref020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5588\/ijtld.17.0721","article-title":"Multicenter study of QuantiFERON-TB Gold Plus in patients with active tuberculosis","volume":"22","author":"DJ Horne","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0234700.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00427-18","article-title":"QuantiFERON-TB Gold Plus is a more sensitive screening tool than QuantiFERON-TB Gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"JY Chien","year":"2018","journal-title":"J Clin Microbiol"},{"key":"pone.0234700.ref022","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5588\/ijtld.12.0927","article-title":"Changes in QuantiFERON-TB Gold In-Tube results during treatment for tuberculous infection","volume":"17","author":"ML Bastos","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0234700.ref023","doi-asserted-by":"crossref","first-page":"e81564","DOI":"10.1371\/journal.pone.0081564","article-title":"Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment","volume":"8","author":"MR Nyendak","year":"2013","journal-title":"PLoS One"},{"key":"pone.0234700.ref024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01976-2016","article-title":"QuantiFERON-TB Gold Plus as a potential tuberculosis treatment monitoring tool","volume":"49","author":"A Kamada","year":"2017","journal-title":"Eur Respir J"},{"key":"pone.0234700.ref025","doi-asserted-by":"crossref","first-page":"15626","DOI":"10.1038\/s41598-018-33825-w","article-title":"Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection","volume":"8","author":"E Petruccioli","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0234700.ref026","volume-title":"Canadian Tuberculosis Standards","author":"Canadian Lung Association, Canadian Thoracic Society, Public Health Agency of Canada, Centre for Communicable Diseases and Infection Control (Canada)","year":"2014","edition":"7"},{"key":"pone.0234700.ref027","first-page":"347","article-title":"Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence?","volume":"14","author":"P Tapaninen","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0234700.ref028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00039896.1968.10665013","article-title":"The eradication of tuberculosis infection by isoniazid chemoprophylaxis","volume":"16","author":"VN Houk","year":"1968","journal-title":"Arch Environ Health"},{"key":"pone.0234700.ref029","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1371\/journal.pmed.0040192","article-title":"Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection","volume":"4","author":"PC Hill","year":"2007","journal-title":"PLoS Med"},{"key":"pone.0234700.ref030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2011.05.008","article-title":"Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection","volume":"370","author":"E Borgstrom","year":"2011","journal-title":"J Immunol Methods"},{"key":"pone.0234700.ref031","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"T Mori","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0234700.ref032","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"JZ Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0234700.ref033","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"E Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0234700.ref034","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1086\/381679","article-title":"Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex","volume":"189","author":"C Aagaard","year":"2004","journal-title":"J Infect Dis"},{"key":"pone.0234700.ref035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-gamma) release assays. a systematic review","volume":"11","author":"S Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"pone.0234700.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","article-title":"QFT-Plus: a plus in variability?\u2014Evaluation of new generation IGRA in serial testing of students with a migration background in Germany","volume":"12","author":"J Knierer","year":"2017","journal-title":"J Occup Med Toxicol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T17:46:04Z","timestamp":1592329564000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234700"}},"subtitle":[],"editor":[{"given":"Katalin Andrea","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0234700","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]}}}